Primary Percutaneous Coronary Intervention in Elderly Patients with ST-elevation Acute Myocardial Infarction

Wei-feng Shen

DOI: https://doi.org/10.1097/00029330-200607020-00001

IF: 6.133

2006-01-01

Chinese Medical Journal

Abstract:The elderly constitute a rapidly growing segment of our population and cardiovascular disease becomes more prevalent with increasing age, accounting for majority of their morbidity and mortality.1,2 ST-elevation acute myocardial infarction (STEMI) is the result of an abrupt cessation of blood supply caused by coronary occlusion, its process involving atherosclerotic plaque rupture or erosion, platelet aggregation and thrombus formation. Early, effective, and persistent recanalization of the infarct-related coronary artery and reperfusion of the myocardium are crucial for the improvement of left ventricular function and prognosis of the patients.3,4 However, the optimal therapeutic strategy or the risk/benefit of reperfusion treatment for STEMI in the elderly remains an unsettled issue because previous large randomized clinical trials assessing reperfusion treatment of STEMI or the relative merits of mechanical versus pharmacological options have systematically excluded elderly patients, with only 10% to 15% of the population being older than 75 years of age.5 Three scenarios of reperfusion therapy in STEMI including intravenous thrombolysis, facilitated percutaneous coronary intervention (PCI), and primary PCI have been investigated extensively over the last decade. The recent American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) guidelines have indicated that thrombolysis may be at least as effective as primary PCI in achieving reperfusion for patients with STEMI who were admitted to a hospital within the first 3 hours after onset of symptoms and whose door-to-balloon time was beyond 90 minutes.6–8 During the first 2–3 hours after onset of symptoms, a striking benefit of reperfusion upon both mortality and myocardial salvage is present, and in this setting, time to treatment is crucial. In addition, previous studies have shown a consistent impact of time of thrombolysis on mortality, with the lowest mortality in the earlier treatment group, regardless of the extent of ST-segment resolution. Subsequently, benefits persist but these are of decreasing magnitude over time. At this stage, the priority is to open the vessel and the time to treatment is of less importance. Because the maximum efficacy of thrombolytic therapy is achieved when the treatment is initiated within the first hour of symptom onset, pre-hospital reperfusion strategies (pre-hospital initiation of thrombolytic therapy) have been recommended.9 However, pre-hospital thrombolysis has not been well organized on a widespread basis in China, and a relatively high failure rate in achieving optimal recanalization and reperfusion together with a relatively high complication rate is apparent especially in elderly patients. Randomized clinical thrombolytic trials and registry data have shown that the risk of intracranial hemorrhage increases with age, more so with fibrin-specific agents than non-specific agents,10 and thrombolysis is often not indicated for very old patients especially in octogenarians. Facilitated PCI for STEMI is defined as the use of pharmacological substances before a planned immediate intervention, to improve coronary patency. Previous randomized clinical trials combining full-dose thrombolytic and/or potent adjunctive antiplatelet or anticoagulant therapy with subsequent PCI to improve reperfusion and/or reduce reocclusion generally showed an unfavorable trend to more complications and an increased mortality rate.8,11,12 In a meta-analysis of 17 randomized controlled clinical trials, Keeley et al11 revealed that facilitated PCI resulted in a greater than 2-fold increase in the number of patients with initial TIMI grade 3 flow, compared with the primary approach; however, final rates did not differ. The patients assigned to the facilitated approach died more than those assigned to the primary approach, and had higher non-fatal reinfarction and urgent target vessel revascularization rates.11 Facilitated intervention was also associated with higher rates of major bleeding than primary intervention, which is particularly true for thrombolytic therapy-containing facilitated regimens. Thus, facilitated PCI offers no benefit over primary PCI in STEMI treatment and facilitated interventions with thrombolytic-based regimens should be avoided especially in the elderly.11 A large body of clinical evidence has shown more favorable short-term outcomes in STEMI patients with the primary PCI, provided that the extra delay anticipated by a PCI strategy versus immediate administration of a fibrin-specific thrombolytic agent (PCI-related delay) is less than 60 minutes.5,12,13 Many trials have indicated that primary PCI, particularly with stent implantation, may be more effective than thrombolysis in elderly patients in improving left ventricular function and reducing one-year mortality, associated with significantly lower rates of cerebral hemorrhage and other end points.10,14,15 Among patients older than 75 years with STEMI complicated by cardiogenic shock, outcomes may be better than previously believed when early revascularization is performed.7 Recent ACC/AHA and ESC guidelines have recommended primary PCI as the preferred reperfusion strategy when performed by experienced operators in a timely fashion.6–8 The treatment algorithms advocate reperfusion therapy for all patients with STEMI within 12 hours after onset of symptoms, and primary PCI may be better performed within 90 minutes after medical contact.8 Delays in door-to-balloon time with primary PCI for STEMI have a major impact on late cardiac mortality, and this survival impact is seen primarily in high-risk patients instead of low-risk patients and in patients presenting early but not late after the onset of symptoms.15 Efficient systems of transfer may provide the opportunity for wider use of primary PCI, especially for patients with contra-indications to thrombolysis.16 These findings have implications for the triage of patients with STEMI for primary PCI. In this issue of Chinese Medical Journal Zhang et al17 provided useful information regarding the clinical efficacy of primary PCI with adjunctive stenting for STEMI in patients aged older than 75 years. In this randomized study, primary coronary stenting reduced in-hospital mortality especially for patients with diabetes, anterior myocardial infarction and Killip class III/IV at presentation. Furthermore, such short-term beneficial effects of primary PCI for STEMI in elderly patients can be maintained during one-year clinical follow-up, with a significant reduction of major adverse cardiac event rate. The striking paucity of complications during the hospital stay and during one-year follow-up may be credited to patient selection, judicious use of coronary stents (especially drug-eluting stents) and skillful care. This study corroborates previous findings that PCI improved quality of life even for octogenarians,1,2,18 and seemed to justify general recommendation to use primary PCI more often in the elderly.19 Although the procedural technique itself in the elderly often becomes difficult due to vascular access and coronary tortuosity and calcification, and majority of elderly patients have multi-vessel disease making complete revascularization difficult during acute and recovery phases, event-free survival was superior to those without mechanical reperfusion. Primary PCI has been improved considerably during the last decade, making this approach safer and more successful. Furthermore, the introduction of stents and glycoprotein IIb/IIIa antagonists has been milestones, resulting in mechanical reperfusion therapy being advocated as routine care in the elderly with STEMI. Recent data suggested that the introduction of drug-eluting stents in primary PCI might further improve the clinical outcomes by reducing restenosis and target vessel revascularization. In spite of encouraging results, the threshold of complications during pri mary PCI for STEMI patients with advanced age should remain high, therefore, attention directed at post-procedural monitoring of patient’s conditions is mandatory. At present, timely rapid primary PCI with routine adjunctive coronary stenting is available in many centers in China due to improvement in necessary facilities and skilled personnel. This may be particularly attractive as more elderly are eligible. Primary PCI with stent implantation should improve infarct-related artery patency, myocardial reperfusion and survival, and reduce the risk of intracranial hemorrhage as compared with thrombolysis in this cohort, provided that meticulous care has been taken to reduce the risk of major bleeding at vascular access and renal failure after procedures. The effects of coronary drug-eluting stents in primary PCI for elderly patients with STEMI need further clinical investigations.20,21